Design, Synthesis, and Biological Evaluation of 5-Amino-4-fluoro-1 H -benzo[ d ]imidazole-6-carboxamide Derivatives as Novel and Potential MEK/RAF Complex Inhibitors Based on the “Clamp” Strategy
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Peng Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Drug Design, Protein Kinase Inhibitors, Antineoplastic Agents, Cell Proliferation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: West China Hospital, Sichuan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Herein, we described the rational drug design and synthesis of a series of 5-amino-4-fluoro-1H-benzo[d]imidazole-6-carboxamide derivatives that inhibit MEK and RAF kinases. The detailed screening cascades revealed that 16b was a preferred compound, which might act like a "clamp" to stabilize the MEK/RAF complex, thereby effectively inhibiting MEK1, BRAF, and BRAFV600E with IC50 values of 28, 3, and 3 nM, respectively. 16b possessed an excellent selectivity over other 312 human-related kinases at 1 μM. In vitro, 16b showed potent antiproliferative activities against MIA PaCa-2 (G12C KRAS), HCT116 (G13D KRAS), and C26 (G12D KRAS) cells with IC50 values of 0.011, 0.079, and 0.096 μM, respectively. CoIP experiments demonstrated that 16b could induce MEK/RAF complex formation. Most importantly, in the C26 syngeneic colorectal and HCT116 mice xenograft tumor models, 16b demonstrated tumor growth inhibition of 70 and 93%, respectively, suggesting that 16b may be a promising MEK/RAF complex inhibitor and worthy of further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Tao Yang, Lijuan Chen
Förderung
- West China Hospital, Sichuan University
- National Natural Science Foundation of China
Zitieren
APA
Wang, P., Yuan, Y., Yang, T., Zou, Y., Tang, M., Ma, Z., Bo, W., Qin, S., Chen, Y., Guo, T., Guo, Z., Yang, J., Xiang, M., & Chen, L. (2024). Design, Synthesis, and Biological Evaluation of 5-Amino-4-fluoro-1 H -benzo[ d ]imidazole-6-carboxamide Derivatives as Novel and Potential MEK/RAF Complex Inhibitors Based on the “Clamp” Strategy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00860
Vancouver
Wang P, Yuan Y, Yang T, Zou Y, Tang M, Ma Z, et al. Design, Synthesis, and Biological Evaluation of 5-Amino-4-fluoro-1 H -benzo[ d ]imidazole-6-carboxamide Derivatives as Novel and Potential MEK/RAF Complex Inhibitors Based on the “Clamp” Strategy. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00860
BibTeX
@article{Wang2024,
author = {Wang, Peng and Yuan, Yongting and Yang, Tao and Zou, Yurong and Tang, Minghai and Ma, Ziyan and Bo, Weichen and Qin, Songhui and Chen, Yong and Guo, Tao and Guo, Zhongning and Yang, Jianhong and Xiang, Mingli and Chen, Lijuan},
title = {Design, Synthesis, and Biological Evaluation of 5-Amino-4-fluoro-1 H -benzo[ d ]imidazole-6-carboxamide Derivatives as Novel and Potential MEK/RAF Complex Inhibitors Based on the “Clamp” Strategy},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00860}
}
EUVIMED